Nurse Practitioner · Montgomery, AL
NPI
1861052144
Since 2019
Specialty
Nurse Practitioner
Code 363L00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
4760 Woodmere Blvd
Montgomery, AL, 36106
Phone (334) 288-0814
Groups this clinician bills Medicare through
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$608K
1,418 prescriptions
Company payments, 2025
$306
From 2 companies
Medicare prescription drug claims, 2024
In 2024, the drug Caroline K Lynn prescribed most often to Medicare patients was Sevelamer Carbonate, with 169 prescriptions and refills. In total Caroline K Lynn wrote 1,418 Medicare prescriptions that cost $608K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-06-18.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Sevelamer Carbonate Generic | 169 | 286 | 50 | $38K |
| Carvedilol Generic | 141 | 319 | 52 | $956 |
| Auryxia Ferric Citrate | 129 | 171 | 34 | $284K |
| Hydralazine Hcl Generic | 120 | 247 | 47 | $1,937 |
| Losartan Potassium Generic | 119 | 282 | 42 | $877 |
| Amlodipine Besylate Generic | 102 | 210 | 37 | $521 |
| Velphoro Sucroferric Oxyhydroxide | 67 | 83 | 22 | $223K |
| Lidocaine-Prilocaine Lidocaine/Prilocaine | 56 | 60 | 15 | $930 |
| Clonidine Hcl Generic | 52 | 100 | 14 | $334 |
| Calcium Acetate Generic | 46 | 62 | 12 | $5,128 |
| Nifedipine Er Nifedipine | 40 | 70 | Under 11 | $636 |
| Atorvastatin Calcium Generic | 29 | 45 | Under 11 | $215 |
| Midodrine Hcl Generic | 26 | 63 | 15 | $2,473 |
| Omeprazole Generic | 23 | 55 | Under 11 | $258 |
| Lokelma Sodium Zirconium Cyclosilicate | 17 | 18 | Under 11 | $8,547 |
Brand drugs: 254 claims; generic drugs: 1,164 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Caroline K Lynn $306 ($306 in general payments such as food, travel and fees) from 2 companies. The largest payer was Fresenius USA Marketing, Inc. with $278.
| Company | Payments | Amount |
|---|---|---|
| Fresenius USA Marketing, Inc. | 23 | $278 |
| Akebia Therapeutics Inc AKBA | 1 | $27.79 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.